PRJNA758380
Inhibition of gut microbial beta-glucuronidase prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis
We assessed the chemoprotective effects and associated changes in gut microbiota induced by pre-administration of bacterial-specific betaG inhibitor TCH-3511 in carcinogen azoxymethane (AOM)-treated APCMin/+ mice.